U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula 2C3H5O3.Cu.2H2O
Molecular Weight 277.717
Optical Activity ( + / - )
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CUPRIC LACTATE DIHYDRATE

SMILES

O.O.[Cu++].CC(O)C([O-])=O.CC(O)C([O-])=O

InChI

InChIKey=HTHHRDNMPSRDOD-UHFFFAOYSA-L
InChI=1S/2C3H6O3.Cu.2H2O/c2*1-2(4)3(5)6;;;/h2*2,4H,1H3,(H,5,6);;2*1H2/q;;+2;;/p-2

HIDE SMILES / InChI

Description

A copper fungicide.

CNS Activity

CNS Penetrant
2554
Curator's Comment: Chronic copper toxicity causes differential copper buildup in cortex, cerebellum and striatum region of central nervous system of male Wistar rats

Approval Year

Unknown
139594
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Electrochemical CO2 reduction on Cu2O-derived copper nanoparticles: controlling the catalytic selectivity of hydrocarbons.
2014 Jun 28
Medical applications of Cu, Zn, and S isotope effects.
2016 Oct 1
Patents

Patents

US20040105894
2
US2456727
2
US2555385
2

Sample Use Guides

In Vivo Use Guide
Rats: intraperitoneally injected copper lactate (0.15 mg Cu/100 g body weight) daily for 90 days
Route of Administration: Intraperitoneal
In Vitro Use Guide
Unknown
Name Type Language
CUPRIC LACTATE DIHYDRATE
Common Name English
PROPANOIC ACID, 2-HYDROXY-, COPPER(2+) SALT, HYDRATE (2:1:2)
Systematic Name English
DL-LACTIC ACID COPPER SALT DIHYDRATE [MI]
Common Name English
Code System Code Type Description
MERCK INDEX
m6654
Created by admin on Sat Dec 16 09:04:56 GMT 2023 , Edited by admin on Sat Dec 16 09:04:56 GMT 2023
PRIMARY Merck Index
CAS
5893-64-1
Created by admin on Sat Dec 16 09:04:56 GMT 2023 , Edited by admin on Sat Dec 16 09:04:56 GMT 2023
PRIMARY
FDA UNII
LPP55U0ABO
Created by admin on Sat Dec 16 09:04:56 GMT 2023 , Edited by admin on Sat Dec 16 09:04:56 GMT 2023
PRIMARY
PUBCHEM
72941466
Created by admin on Sat Dec 16 09:04:56 GMT 2023 , Edited by admin on Sat Dec 16 09:04:56 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966